---
title: "北大醫藥股份有限公司 (000788.SZ)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/000788.SZ.md"
symbol: "000788.SZ"
name: "北大醫藥股份有限公司"
industry: "制藥"
---

# 北大醫藥股份有限公司 (000788.SZ)

| Item | Detail |
|------|--------|
| Industry | 制藥 |
| Location | 滬深市場 |
| Website | [www.pku-hc.com](https://www.pku-hc.com) |

## Company Profile

公司其前身為始建于 1965 年的西南合成制藥廠，1997 年于深圳證券交易所成功上市，秉承 “創新、責任、信任、努力” 的核心價值觀，以 “原料制劑一體化仿創型醫藥科技企業” 為戰略定位，圍繞 “抗感染、鎮痛類、精神類、慢病類” 等核心領域重點發展醫藥工業。公司主要從事化學藥品制劑的研發、生產和銷售，醫藥流通以及醫療服務等業務。公司主要產品：注射用頭孢曲松鈉、注射用美羅培南、注射用頭孢米諾鈉、鹽酸莫西沙星注射液、鹽酸克林黴素棕櫚酸酯顆粒、萘丁美酮膠囊、塞來昔布膠囊、右酮洛芬片、右酮洛芬膠囊、鹽酸丁螺環酮片、奧氮平片。企業榮譽：國家級技術中心，是中國醫藥重點骨幹企業，國家創新型試點企業，國家火...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-21T04:30:11.000Z

**Overall: C (0.42)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 159 / 222 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -15.24% |  |
| Net Profit YoY | 11.69% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.28 |  |
| Dividend Ratio | 0.97% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3.69B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 1.76B |  |


**Multi Score**: C

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 9.11% | B |
| Profit Margin | 8.17% | B |
| Gross Margin | 31.24% | C |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -15.24% | E |
| Net Profit YoY | 11.69% | C |
| Total Assets YoY | -9.83% | E |
| Net Assets YoY | 5.08% | B |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 1223.38% | B |
| OCF YoY | -15.24% | E |

#### Operating Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.79 | B |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 23.09% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 北大醫藥股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "9.11%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "8.17%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "31.24%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-15.24%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "11.69%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-9.83%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "5.08%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "1223.38%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "-15.24%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "B",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.79",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "23.09%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 艾力斯 (SH.688578) | A | A | B | A | B | A |
| 02 | 興齊眼藥 (SZ.300573) | A | A | A | B | B | A |
| 03 | 恆瑞醫藥 (SH.600276) | A | B | C | A | B | B |
| 04 | 雲南白藥 (SZ.000538) | B | C | B | B | C | B |
| 05 | 信立泰 (SZ.002294) | B | B | C | A | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 25.69 | 61/222 | 27.72 | 26.22 | 24.64 |
| PB | 2.28 | 88/222 | 2.45 | 2.33 | 2.25 |
| PS (TTM) | 2.10 | 38/222 | 2.14 | 1.86 | 1.71 |
| Dividend Yield | 0.97% | 103/222 | 1.62% | 1.28% | 0.97% |

## References

- [Company Overview](https://longbridge.com/en/quote/000788.SZ/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/000788.SZ/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/000788.SZ/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.